1. Home
  2. VANI vs PRE Comparison

VANI vs PRE Comparison

Compare VANI & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VANI
  • PRE
  • Stock Information
  • Founded
  • VANI 1998
  • PRE 2014
  • Country
  • VANI United States
  • PRE Hong Kong
  • Employees
  • VANI N/A
  • PRE N/A
  • Industry
  • VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • PRE Biotechnology: Laboratory Analytical Instruments
  • Sector
  • VANI Health Care
  • PRE Industrials
  • Exchange
  • VANI Nasdaq
  • PRE Nasdaq
  • Market Cap
  • VANI 65.2M
  • PRE N/A
  • IPO Year
  • VANI 2014
  • PRE N/A
  • Fundamental
  • Price
  • VANI $1.07
  • PRE $3.91
  • Analyst Decision
  • VANI Strong Buy
  • PRE Buy
  • Analyst Count
  • VANI 1
  • PRE 1
  • Target Price
  • VANI $4.00
  • PRE $9.00
  • AVG Volume (30 Days)
  • VANI 102.7K
  • PRE 7.8K
  • Earning Date
  • VANI 03-31-2025
  • PRE 04-08-2025
  • Dividend Yield
  • VANI N/A
  • PRE N/A
  • EPS Growth
  • VANI N/A
  • PRE N/A
  • EPS
  • VANI N/A
  • PRE N/A
  • Revenue
  • VANI N/A
  • PRE $25,561,362.00
  • Revenue This Year
  • VANI N/A
  • PRE $51.43
  • Revenue Next Year
  • VANI N/A
  • PRE $131.29
  • P/E Ratio
  • VANI N/A
  • PRE N/A
  • Revenue Growth
  • VANI N/A
  • PRE N/A
  • 52 Week Low
  • VANI $1.03
  • PRE $2.85
  • 52 Week High
  • VANI $2.22
  • PRE $7.84
  • Technical
  • Relative Strength Index (RSI)
  • VANI 41.41
  • PRE 30.92
  • Support Level
  • VANI $1.06
  • PRE $3.62
  • Resistance Level
  • VANI $1.16
  • PRE $4.54
  • Average True Range (ATR)
  • VANI 0.04
  • PRE 0.28
  • MACD
  • VANI 0.01
  • PRE -0.02
  • Stochastic Oscillator
  • VANI 28.85
  • PRE 31.52

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a preclinical-stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division.

Share on Social Networks: